Quest Diagnostics Inc. logo

Quest Diagnostics Inc. (DGX)

Market Closed
15 Oct, 08:00 PM
NYSE NYSE
$
239. 15
+5.72
+2.4504%
$
25.49B Market Cap
20.12 P/E Ratio
5.98% Div Yield
1M Volume
8.71 Eps
$ 233.43
Previous Close
Add Transaction
Day Range
235.57 239.17
Year Range
171.18 248.84
Want to track DGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026

5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026

FAST, GD, UNH, TXRH and DGX are five stocks that combine long records of uninterrupted payouts with stable earnings and solid cash flow.

Zacks | 2 months ago
Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus

Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus

DGX's Q2 results may reflect growth across physician, hospital and consumer channels as AI tools and advanced diagnostics gain traction.

Zacks | 3 months ago
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 3 months ago
DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH

DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH

Quest Diagnostics gains NYSDOH approval for Haystack MRD, expanding the cancer test to all 50 states and strengthening its oncology reach.

Zacks | 3 months ago
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?

Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?

DGX gains from Advanced Diagnostics, physician and consumer testing growth, plus AI-driven efficiency efforts, even as debt and policy risks linger.

Zacks | 3 months ago
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know

Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 4 months ago
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?

Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?

Here is how Quest Diagnostics (DGX) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Zacks | 4 months ago
Loading...
Load More